Basic Information
Basic information for LINC00662-270-33aa-2
Peptide Name LINC00662-270-33aa-2
Genome Position chr19:27722522-27722620[-]
Species Human
Peptide Sequence MLCDVWIHLTELNLYFYSTPWKHSFCSIYEGTF
Peptide Length 33
Unique No (LINC00662-231-33aa-2,LINC00662-242-33aa-2)
Grand Average of Hydropathicity 0.2182
Relative Molecular Mass 4622.22
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000261824;LINC00662
Transcript ID/Name ENST00000668933;LINC00662-270
Transcript Length 6446
Coding Ability 0.3314
DNA Sequence Corresponding to Peptide ATGCTTTGTGATGTGTGGATTCATCTCACAGAGTTAAACTTATATTTTTATTCAACACCTTGGAAACACTCTTTTTGTAGCATCTATGAAGGGACATTC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :